R&D Tax Relief Calculator UK
Calculate Corporation Tax credits under the consolidated Merged RDEC scheme (20%) and Enhanced R&D Intensive Support (ERIS 26.97%) for innovative companies and tech SMEs.
Company Status & R&D Expenditure
Merged RDEC scheme & ERIS rules for accounting periods starting on or after 1 April 2024.
Required to evaluate 30% ERIS intensity.
Gross wages, employer Class 1 NIC, and workplace pension contributions.
Qualifying: £52,000.00
Qualifying: £26,000.00
AWS/Azure cloud hosting for R&D, lab materials, CAD tools, and software licences.
Side-by-Side Scheme Comparison (Post-April 2024 Rules)
| Statutory Scheme | Gross Rate | Net Return | Net Cash Benefit |
|---|---|---|---|
| Merged RDEC (Unified) | 20.0% | 15.0% | £68,700.00 |
| ERIS (R&D Intensive SME)Requires ≥30% intensity & loss | 186.0% | 26.97% | £123,522.60 |
Eligible Expenditure Summary
How the UK R&D Tax Relief Architecture Works in 2026/27
Following landmark reforms enacted in the Finance Act 2024, the UK replaced its historical two-tier R&D framework with a streamlined structure. For accounting periods beginning on or after 1 April 2024, the old SME scheme and the large-company RDEC scheme were merged into a single Merged RDEC Scheme, preserving a targeted scheme called Enhanced R&D Intensive Support (ERIS) for loss-making SMEs.
Under the unified Merged RDEC Scheme, companies receive a taxable expenditure credit equal to 20% of their Qualifying R&D Expenditure (QRE). Because this credit is treated as taxable trading income, its net value after Corporation Tax is 15.0% for companies subject to the 25% main rate, or 16.2% for companies paying the 19% small profits rate.
Merged RDEC Scheme vs Enhanced R&D Intensive Support (ERIS)
| Feature | Merged RDEC Scheme | ERIS (R&D Intensive SME) |
|---|---|---|
| Eligible Companies | All companies (Large & Non-Intensive SMEs) | Loss-making SMEs meeting ≥30% R&D intensity |
| Statutory Relief Mechanism | 20% gross taxable expenditure credit | 186% enhanced deduction (100% cost + 86% extra) |
| Net Benefit Rate | 15.0% (at 25% CT) / 16.2% (at 19% CT) | Up to 26.97% payable cash credit |
| Payable Credit Loss Surrender | Subject to 7-step RDEC offset rules | 14.5% flat cash surrender on trading loss |
| Subcontractor Treatment | Customer claims if contracted out (65%) | 65% on qualifying UK subcontracts |
Qualifying Expenditure Categories
Frequently Asked Questions About UK R&D Tax Credits
Frequently Asked Questions
Clear answers based on official HMRC rules and statutory guidance.
Recommended Resources
Related Corporate Tax Calculators
Explore connected UK tax tools, Patent Box models, and company director remuneration guides.
Related Calculators
All CalculatorsPatent Box Tax Calculator
Model your 10% effective Corporation Tax rate on patented technology profits.
Corporation Tax Calculator
Calculate standard 19% small profits and 25% main rate company taxes.
Cost of Employment Calculator
Calculate employer Class 1 NICs, pension contributions, and true staff costs.
Director Salary & Dividend Calculator
Optimise limited company extraction alongside corporate R&D tax planning.
Compare Common UK Salaries
All Salary BracketsStatutory Tax Guides & Blog
Visit Blog HubDirector Salary & Dividend Guide 2026/27
Comprehensive remuneration strategies, £12,570 salary, and CT rates.
How UK Income Tax Works (2026/27)
Personal allowance, tax bands, and HMRC PAYE deduction rules.
UK Tax Brackets 2026/27
Comprehensive statutory rate tables across England, Wales, and Scotland.
A screening estimate, not an R&D decision
Eligibility depends on a qualifying science or technology advance and the accounting period. Commercial novelty or routine software work alone does not establish eligibility.
Merged R&D expenditure credit and Enhanced R&D Intensive Support have distinct eligibility, intensity, subsidy and loss-making conditions. Taxable credits and offsets may change the net cash result.
Check the rules for your circumstances
Official guidance supports the rules described here; it does not approve or certify this calculator. Confirm dates, eligibility and unsupported cases before making a financial decision.